Genomics companies in Lithuania
3 genomics profiles in Lithuania. Every profile is hand-reviewed with leadership, certifications, and public sources.
Where does genomics cluster in Lithuania?
Vilnius (2) and Kaunas (1) Most visible profiles: Genomika, Saidė Genomics, and CasZyme.
Which standards are already visible?
Not yet available. Latest review: 21 March 2026. Review cycle: March 2026.
Genomics profiles in Lithuania
3 profiles match the active filter.
Genomika
KaunasLithuaniaGenomics
Kaunas applied-biotechnology research company providing genomics, bioinformatics, wet-lab execution, experimental design, and DNA-storage related development services.
- Lead
- Mantas SimutisChief Executive Officer
- Scale
- Applied genomics and biotechnology services platform
Saidė Genomics
VilniusLithuaniaGenomics
Vilnius molecular-diagnostics and genomics laboratory delivering NIPT, pharmacogenomics, cancer testing, sequencing services, and personalized research workflows from Lithuania.
- Lead
- Arūnas LeipusDirector
- Scale
- Clinical genomics and sequencing platform
CasZyme
VilniusLithuaniaGenomics
Vilnius CRISPR enzyme-discovery and genome-editing company building programmable nuclease platforms, custom research programs, and translational partnerships from its Lithuanian R&D base.
- Lead
- Dr. Giedrius GasiūnasChief Executive Officer and Co-Founder
- Scale
- Molecular
Frequently asked questions on this category
- What is a genomics company?
- Companies developing or providing genomic and sequencing technologies — DNA/RNA sequencing platforms, single-cell analysis, gene editing tools, population genomics infrastructure, bioinformatics services, or clinical molecular diagnostics. Many overlap with diagnostics; the genomics filter is for organizations whose primary business is genome-scale analysis.
- Which European countries lead in genomics?
- Estonia leads per capita (Estonian Genome Project, Asper Biogene, Tartu cluster). Lithuania has a strong CRISPR/Cas IP base (CasZyme, Atrandi). Germany hosts deep industrial genomics (Qiagen, CeGaT). The Nordics carry strong population genomics and clinical sequencing programs (Sweden, Denmark, Iceland).
- What is the difference between genomics and diagnostics?
- Diagnostics is broader — any test that identifies disease or biological state (immunoassays, PCR, biochemistry, imaging, etc.). Genomics specifically uses DNA/RNA-level analysis. Many genomics companies sell their tests as IVDs (regulated diagnostics under EU IVDR), so the categories overlap. Use the genomics filter when sequencing or genome-scale analysis is the core capability; use diagnostics when broader testing portfolio is the focus.
- How are genomics companies verified in this directory?
- Every profile is hand-reviewed: leadership confirmed by primary source, physical site address sourced from official disclosures, capability claims backed by published patents, certifications (ISO 13485 where applicable), or peer-reviewed publications, and a registry note explaining current operating context.
Compare companies or open the wider market.
Use the compare tool to view two or three companies side by side, or open the country hub for the full market view.
